Avanir Pharmaceuticals, Inc. Watch

from 8-K 41 pages Avanir Pharmaceuticals, Inc. 18,200,000 Shares of Common Stock Underwriting Agreement

from 8-K 3 pages Avanir Pharmaceuticals, Inc. Amendment No. 3 to Sales Agreement

from 8-K 3 pages Avanir Pharmaceuticals, Inc. Amendment No. 2 to Sales Agreement

from S-3 3 pages Avanir Pharmaceuticals, Inc. Amendment No. 1 to Sales Agreement

from S-3 35 pages Avanir Pharmaceuticals, Inc. $25,000,000 Sales Agreement

from 8-K 37 pages 20,000,000 Shares Avanir Pharmaceuticals, Inc. Common Stock ($0.0001 Par Value Per Share) Underwriting Agreement

from 8-K 36 pages 10,000,000 Avanir Pharmaceuticals, Inc. Common Stock ($0.0001 Par Value Per Share) Underwriting Agreement

from 8-K 42 pages 34,972,678 Shares Warrants to Purchase 12,240,437 Shares Avanir Pharmaceuticals Common Stock Placement Agency Agreement

from SC 13G 1 page Joint Filing Agreement Exhibit 1.1 Joint Filing Agreement the Undersigned Hereby Agree That the Statement on This Schedule 13g, Dated May 26, 2004, (The "Schedule 13g"), With Respect to the Common Stock, No Par Value Per Share, of Avanir Pharmaceuticals Is Filed on Behalf of Each of US Pursuant to and in Accordance With the Provisions of Rule 13d-1(k) Under the Securities and Exchange Act of 1934, as Amended, and That This Agreement Shall Be Included as an Exhibit to This Schedule 13g. Each of the Undersigned Agrees to Be Responsible for the Timely Filing of the Schedule 13g, and for the Completeness and Accuracy of the Information Concerning Itself Contained Therein. This Agreement May Be Executed in Any Number of Counterparts, All of Which Taken Together Shall Constitute One and the Same Instrument. in Witness Whereof, the Undersigned Have Executed This Agreement as of the 20th Day of July 2004. Orbimed Advisors LLC By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: President Orbimed Capital II LLC By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: Managing Member By: /S/ Samuel D. Isaly Name: Samuel D. Isaly

from SC 13G 1 page Joint Filing Agreement Exhibit 1.1 Joint Filing Agreement the Undersigned Hereby Agree That the Statement on This Schedule 13g, Dated May 26, 2004, (The "Schedule 13g"), With Respect to the Common Stock, No Par Value Per Share, of Avanir Pharmaceuticals Is Filed on Behalf of Each of US Pursuant to and in Accordance With the Provisions of Rule 13d-1(k) Under the Securities and Exchange Act of 1934, as Amended, and That This Agreement Shall Be Included as an Exhibit to This Schedule 13g. Each of the Undersigned Agrees to Be Responsible for the Timely Filing of the Schedule 13g, and for the Completeness and Accuracy of the Information Concerning Itself Contained Therein. This Agreement May Be Executed in Any Number of Counterparts, All of Which Taken Together Shall Constitute One and the Same Instrument. in Witness Whereof, the Undersigned Have Executed This Agreement as of the 20th Day of July 2004. Orbimed Advisors LLC By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: President Orbimed Capital II LLC By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: Managing Member By: /S/ Samuel D. Isaly Name: Samuel D. Isaly

from SC 13G 1 page Joint Filing Agreement Exhibit 1.1 Joint Filing Agreement the Undersigned Hereby Agree That the Statement on This Schedule 13g, Dated May 26, 2004, (The "Schedule 13g"), With Respect to the Common Stock, No Par Value Per Share, of Avanir Pharmaceuticals Is Filed on Behalf of Each of US Pursuant to and in Accordance With the Provisions of Rule 13d-1(k) Under the Securities and Exchange Act of 1934, as Amended, and That This Agreement Shall Be Included as an Exhibit to This Schedule 13g. Each of the Undersigned Agrees to Be Responsible for the Timely Filing of the Schedule 13g, and for the Completeness and Accuracy of the Information Concerning Itself Contained Therein. This Agreement May Be Executed in Any Number of Counterparts, All of Which Taken Together Shall Constitute One and the Same Instrument. in Witness Whereof, the Undersigned Have Executed This Agreement as of the 20th Day of July 2004. Orbimed Advisors LLC By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: President Orbimed Capital II LLC By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: Managing Member By: /S/ Samuel D. Isaly Name: Samuel D. Isaly

from 8-K ~50 pages Underwriting agreement

from NT 10-K 1 page Underwriting agreement

from SC 13D ~10 pages Underwriting agreement

from NT 10-K/A 1 page Underwriting agreement